US Stock MarketDetailed Quotes

COYA Coya Therapeutics

Watchlist
  • 6.800
  • -0.040-0.58%
Close Feb 14 16:00 ET
  • 6.800
  • 0.0000.00%
Post 20:01 ET
113.61MMarket Cap-10.46P/E (TTM)

Coya Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
0
3.43M
126.84K
6M
6M
0
0
0
0
0
Operating revenue
--0
--3.43M
--126.84K
--6M
--6M
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
24.87%4.45M
104.69%6.66M
93.44%5.61M
41.72%13.91M
108.98%4.19M
33.89%3.56M
-5.57%3.25M
70.56%2.9M
101.46%9.81M
25.37%2M
Selling and administrative expenses
12.95%2.22M
14.15%2.09M
46.84%2.44M
61.61%7.83M
164.55%2.38M
58.96%1.96M
-8.28%1.83M
131.57%1.66M
109.64%4.85M
22.74%898.65K
-General and administrative expense
12.95%2.22M
14.15%2.09M
46.84%2.44M
61.61%7.83M
164.55%2.38M
58.96%1.96M
-8.28%1.83M
131.57%1.66M
109.64%4.85M
22.74%898.65K
Research and development costs
39.67%2.22M
222.02%4.57M
156.81%3.16M
22.42%6.04M
64.19%1.8M
12.66%1.59M
-2.03%1.42M
25.84%1.23M
94.23%4.94M
28.30%1.1M
Depreciation amortization depletion
0.00%6.84K
0.00%6.84K
0.00%6.84K
0.00%27.36K
0.00%6.84K
-45.07%6.84K
69.60%6.84K
69.60%6.84K
69.60%27.36K
-32.86%6.84K
-Depreciation and amortization
0.00%6.84K
0.00%6.84K
0.00%6.84K
0.00%27.36K
0.00%6.84K
-45.07%6.84K
69.60%6.84K
69.60%6.84K
69.60%27.36K
-32.86%6.84K
Operating profit
-24.87%-4.45M
0.56%-3.24M
-89.06%-5.48M
19.45%-7.9M
190.60%1.82M
-33.89%-3.56M
5.57%-3.25M
-70.56%-2.9M
-101.46%-9.81M
-25.37%-2M
Net non-operating interest income expense
Other net income (expense)
201.83%428.87K
116.67%344.45K
163.45%431.09K
126.28%639.37K
115.82%174.67K
110.46%142.09K
377.60%158.97K
5,523.73%163.63K
-11,225.00%-2.43M
-3,401.68%-1.1M
Gain on sale of security
----
----
----
----
----
----
----
----
---2.5M
---1.12M
Other non- operating income (expenses)
201.83%428.87K
116.67%344.45K
163.45%431.09K
904.14%639.37K
969.64%174.67K
260.45%142.09K
1,353.11%158.97K
5,523.73%163.63K
396.40%63.67K
151.79%16.33K
Income before tax
-17.52%-4.02M
6.58%-2.89M
-84.61%-5.05M
40.68%-7.26M
164.03%1.99M
14.89%-3.42M
9.30%-3.1M
-60.65%-2.74M
-150.31%-12.24M
-90.69%-3.11M
Income tax
723.85K
0
Net income
-17.52%-4.02M
6.58%-2.89M
-84.61%-5.05M
34.77%-7.99M
140.74%1.27M
14.89%-3.42M
9.30%-3.1M
-60.65%-2.74M
-150.31%-12.24M
-90.69%-3.11M
Net income continuous Operations
-17.52%-4.02M
6.58%-2.89M
-84.61%-5.05M
34.77%-7.99M
140.74%1.27M
14.89%-3.42M
9.30%-3.1M
-60.65%-2.74M
-150.31%-12.24M
-90.69%-3.11M
Minority interest income
Net income attributable to the parent company
-17.52%-4.02M
6.58%-2.89M
-84.61%-5.05M
34.77%-7.99M
140.74%1.27M
14.89%-3.42M
9.30%-3.1M
-60.65%-2.74M
-150.31%-12.24M
-90.69%-3.11M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-17.52%-4.02M
6.58%-2.89M
-84.61%-5.05M
34.77%-7.99M
140.74%1.27M
14.89%-3.42M
9.30%-3.1M
-60.65%-2.74M
-150.31%-12.24M
-90.69%-3.11M
Basic earnings per share
23.53%-0.26
38.71%-0.19
-25.00%-0.35
83.30%-0.79
146.72%0.15
18.15%-0.34
40.02%-0.31
-8.54%-0.28
-538.47%-4.73
-30.09%-0.3211
Diluted earnings per share
23.53%-0.26
38.71%-0.19
-25.00%-0.35
83.30%-0.79
146.72%0.15
18.15%-0.34
40.02%-0.31
-8.54%-0.28
-538.47%-4.73
-30.09%-0.3211
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
--
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 03.43M126.84K6M6M00000
Operating revenue --0--3.43M--126.84K--6M--6M--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 24.87%4.45M104.69%6.66M93.44%5.61M41.72%13.91M108.98%4.19M33.89%3.56M-5.57%3.25M70.56%2.9M101.46%9.81M25.37%2M
Selling and administrative expenses 12.95%2.22M14.15%2.09M46.84%2.44M61.61%7.83M164.55%2.38M58.96%1.96M-8.28%1.83M131.57%1.66M109.64%4.85M22.74%898.65K
-General and administrative expense 12.95%2.22M14.15%2.09M46.84%2.44M61.61%7.83M164.55%2.38M58.96%1.96M-8.28%1.83M131.57%1.66M109.64%4.85M22.74%898.65K
Research and development costs 39.67%2.22M222.02%4.57M156.81%3.16M22.42%6.04M64.19%1.8M12.66%1.59M-2.03%1.42M25.84%1.23M94.23%4.94M28.30%1.1M
Depreciation amortization depletion 0.00%6.84K0.00%6.84K0.00%6.84K0.00%27.36K0.00%6.84K-45.07%6.84K69.60%6.84K69.60%6.84K69.60%27.36K-32.86%6.84K
-Depreciation and amortization 0.00%6.84K0.00%6.84K0.00%6.84K0.00%27.36K0.00%6.84K-45.07%6.84K69.60%6.84K69.60%6.84K69.60%27.36K-32.86%6.84K
Operating profit -24.87%-4.45M0.56%-3.24M-89.06%-5.48M19.45%-7.9M190.60%1.82M-33.89%-3.56M5.57%-3.25M-70.56%-2.9M-101.46%-9.81M-25.37%-2M
Net non-operating interest income expense
Other net income (expense) 201.83%428.87K116.67%344.45K163.45%431.09K126.28%639.37K115.82%174.67K110.46%142.09K377.60%158.97K5,523.73%163.63K-11,225.00%-2.43M-3,401.68%-1.1M
Gain on sale of security -----------------------------------2.5M---1.12M
Other non- operating income (expenses) 201.83%428.87K116.67%344.45K163.45%431.09K904.14%639.37K969.64%174.67K260.45%142.09K1,353.11%158.97K5,523.73%163.63K396.40%63.67K151.79%16.33K
Income before tax -17.52%-4.02M6.58%-2.89M-84.61%-5.05M40.68%-7.26M164.03%1.99M14.89%-3.42M9.30%-3.1M-60.65%-2.74M-150.31%-12.24M-90.69%-3.11M
Income tax 723.85K0
Net income -17.52%-4.02M6.58%-2.89M-84.61%-5.05M34.77%-7.99M140.74%1.27M14.89%-3.42M9.30%-3.1M-60.65%-2.74M-150.31%-12.24M-90.69%-3.11M
Net income continuous Operations -17.52%-4.02M6.58%-2.89M-84.61%-5.05M34.77%-7.99M140.74%1.27M14.89%-3.42M9.30%-3.1M-60.65%-2.74M-150.31%-12.24M-90.69%-3.11M
Minority interest income
Net income attributable to the parent company -17.52%-4.02M6.58%-2.89M-84.61%-5.05M34.77%-7.99M140.74%1.27M14.89%-3.42M9.30%-3.1M-60.65%-2.74M-150.31%-12.24M-90.69%-3.11M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -17.52%-4.02M6.58%-2.89M-84.61%-5.05M34.77%-7.99M140.74%1.27M14.89%-3.42M9.30%-3.1M-60.65%-2.74M-150.31%-12.24M-90.69%-3.11M
Basic earnings per share 23.53%-0.2638.71%-0.19-25.00%-0.3583.30%-0.79146.72%0.1518.15%-0.3440.02%-0.31-8.54%-0.28-538.47%-4.73-30.09%-0.3211
Diluted earnings per share 23.53%-0.2638.71%-0.19-25.00%-0.3583.30%-0.79146.72%0.1518.15%-0.3440.02%-0.31-8.54%-0.28-538.47%-4.73-30.09%-0.3211
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----------------Unqualified Opinion with Explanatory Notes--

Trending Stocks

Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Unlock Now